CGSM | SHM | CGSM / SHM | |
Gain YTD | 1.934 | 2.009 | 96% |
Net Assets | 709M | 3.41B | 21% |
Total Expense Ratio | 0.25 | 0.20 | 125% |
Turnover | N/A | 40.00 | - |
Yield | 3.01 | 2.35 | 128% |
Fund Existence | 2 years | 18 years | - |
CGSM | SHM | |
---|---|---|
RSI ODDS (%) | 1 day ago15% | 1 day ago19% |
Stochastic ODDS (%) | N/A | 5 days ago19% |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 1 day ago23% | 1 day ago17% |
TrendMonth ODDS (%) | 1 day ago22% | 1 day ago18% |
Advances ODDS (%) | 1 day ago26% | 1 day ago23% |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | 1 day ago12% | 5 days ago23% |
Aroon ODDS (%) | 1 day ago21% | 1 day ago16% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IHOIX | 21.32 | N/A | N/A |
Hartford International Opportunities I | |||
ICBMX | 16.93 | N/A | N/A |
ICON Natural Resources and Infras Instl | |||
ETNHX | 33.24 | N/A | N/A |
Eventide Healthcare & Life Sciences N | |||
FFPNX | 69.48 | N/A | N/A |
American Funds New Perspective 529-F-2 | |||
EMPTX | 8.85 | N/A | N/A |
UBS Emerging Markets Equity Opp P2 |